QA: Emergent Biosolutions Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001367644_2026_Emergent_Biosolutions_Inc.pdf

Logs

Graph

Absolute values for 0001367644, Emergent Biosolutions Inc

  xvar xval
0 AssetsCurrent 662,500,000
1 IntangibleAssetsNetIncludingGoodwill 436,500,000
2 PropertyPlantAndEquipmentNet 205,400,000
3 remainder_Assets 14,200,000
4 LiabilitiesCurrent 132,200,000
5 LiabilitiesNoncurrent 626,000,000
6 remainder_Liabilities 37,800,000
7 CostOfGoodsAndServicesSold 229,311,710
8 SellingGeneralAndAdministrativeExpense 116,577,573
9 ResearchAndDevelopmentExpense 49,270,083
10 remainder_Expenses 415,330,986
11 remainder_Revenues 654,428,317
12 remainder_NetIncome -23,203,408
13 remainder_ComprehensiveNetIncome -1,687,080
  yvar yval
0 Assets 1,318,600,000
1 Liabilities 796,000,000
2 Expenses 810,490,352
3 Revenues 654,428,317
4 StockholdersEquity 522,600,000
5 NetIncome -179,265,443
6 ComprehensiveNetIncome -180,108,983
7 BaseVar 1,802,204,578
8 EconomicCapitalRatiobeforeLimitedLiability 0.907
9 EconomicCapitalRatio 2.23

Edgar->Model Mapping

Feature Distribution

Change over Time